These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 189193)

  • 21. Effect of common duct drainage on serum cholesterol.
    De Palma RG; Hubay CA; Insull W
    Surg Forum; 1965; 16():388-9. PubMed ID: 5319682
    [No Abstract]   [Full Text] [Related]  

  • 22. Increased binding of LDL and VLDL to apo B,E receptors of hepatic plasma membrane of rats treated with Fibernat.
    Venkatesan N; Devaraj SN; Devaraj H
    Eur J Nutr; 2003 Oct; 42(5):262-71. PubMed ID: 14569407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial hypercholesterolemia: unraveling a genetic receptor disease.
    Brown MS; Goldstein JL
    Trans Assoc Am Physicians; 1977; 90():91-108. PubMed ID: 205984
    [No Abstract]   [Full Text] [Related]  

  • 24. Familial hypercholesterolemia: diagnosis, metabolic defect and management.
    Jackson RL; Smith LC; Taunton OD; Gotto AM
    Life Sci; 1977 Nov; 21(10):1395-402. PubMed ID: 200809
    [No Abstract]   [Full Text] [Related]  

  • 25. [Evaluation of the therapeutic efficacy of pravastatin in monothereapy and in association with gemfibrozil in hypercholesterolemia associated with moderate hyperglyceridemia].
    Napoli C; Lepore S; Ambrosio G; Chiariello M
    Cardiologia; 1992 Nov; 37(11):761-8. PubMed ID: 1298545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Functional and structural changes in the small intestine during experimental hypercholesteremia].
    Lebedev NN; Martsevich MS; Klimenko ED; Leskova GF; Kranchev AK
    Biull Eksp Biol Med; 1983 Nov; 96(11):16-20. PubMed ID: 6640091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction between high density and low density lipoproteins uptake and degradation by cultured human fibroblasts.
    Miller NE; Weinstein DB; Carew TE; Koschinsky T; Steinberg D
    J Clin Invest; 1977 Jul; 60(1):78-88. PubMed ID: 194923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased very low density lipoprotein fluidity in familial hypercholesterolemia.
    Klein L; Aviram M; Brook GJ; Mokady S; Cogan U
    Isr J Med Sci; 1991 Feb; 27(2):70-4. PubMed ID: 2004886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of colestipol on the metabolism of very-low-density lipoproteins in man.
    Witztum JL; Schonfeld G; Weidman SW
    J Lab Clin Med; 1976 Dec; 88(6):1008-18. PubMed ID: 186544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperlipidemia in coronary heart disease: a biochemical genetic approach.
    Goldstein JL; Brown MS
    J Lab Clin Med; 1975 Jan; 85(1):15-25. PubMed ID: 49382
    [No Abstract]   [Full Text] [Related]  

  • 31. The biochemistry of familial hypercholesterolaemia.
    Myant NB
    Biochem Soc Trans; 1976; 4(4):580-4. PubMed ID: 187482
    [No Abstract]   [Full Text] [Related]  

  • 32. A Q136Stop mutation in the ARH gene causing autosomal recessive hypercholesterolaemia with severely delayed LDL catabolism.
    Tietge UJ; Genschel J; Schmidt HH
    J Intern Med; 2003 May; 253(5):582-3. PubMed ID: 12702036
    [No Abstract]   [Full Text] [Related]  

  • 33. Homozygous familial hypercholesterolemia (receptor-negative type). Repository identification No. GM-361.
    Goldstein JL; Brown MS; Greene AE; Coriell LL
    Cytogenet Cell Genet; 1975; 15(5):357-9. PubMed ID: 177249
    [No Abstract]   [Full Text] [Related]  

  • 34. Expression of the familial hypercholesterolemia gene in heterozygotes: model for a dominant disorder in man.
    Goldstein JL; Brown MS
    Trans Assoc Am Physicians; 1974; 87():120-31. PubMed ID: 4376290
    [No Abstract]   [Full Text] [Related]  

  • 35. Familial hypercholesterolaemia.
    Lancet; 1977 Apr; 1(8014):733-4. PubMed ID: 66524
    [No Abstract]   [Full Text] [Related]  

  • 36. New directions in human biochemical genetics: understanding the manifestations of receptor deficiency states.
    Brown MS; Goldstein JL
    Prog Med Genet; 1976; 1():103-19. PubMed ID: 180564
    [No Abstract]   [Full Text] [Related]  

  • 37. [Usefulness of extracorporeal blood purification methods in prevention and treatment of cardiovascular diseases].
    Chrzanowski W
    Pol Arch Med Wewn; 2000 Oct; 104(4):685-93. PubMed ID: 11392157
    [No Abstract]   [Full Text] [Related]  

  • 38. Portacaval shunt for homozygous hypercholesterolaemia.
    Russell D; Mieny C; Heimann KW; Dinner M; Levin SE; Joffe BI; Mendelsohn D; Mega de Andrade A; Lieberthal S; Seftel HC
    Lancet; 1976 Nov; 2(7996):1205. PubMed ID: 63035
    [No Abstract]   [Full Text] [Related]  

  • 39. Xenotransplanting hepatocytes: the triumph of a cup half full.
    Platt JL
    Nat Med; 1997 Jan; 3(1):26-7. PubMed ID: 8986734
    [No Abstract]   [Full Text] [Related]  

  • 40. Cholesterol policy: what should we do? How should we decide?
    Kottke TE; Brekke ML
    J Clin Epidemiol; 1990; 43(10):1023-7. PubMed ID: 2213067
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.